SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
zm
Lv3
270 积分
2020-12-24 加入
最近求助
最近应助
互助留言
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
9小时前
待确认
Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study
13小时前
已完结
Advances in the research of CXCL16 and psoriasis
7个月前
已完结
CXCL9, 10, 11/CXCR3 Axis Contributes to the Progress of Primary Sjogren’s Syndrome by Activating GRK2 to Promote T Lymphocyte Migration
7个月前
已完结
Role of the CXCR6/CXCL16 axis in autoimmune diseases
7个月前
已完结
In their own words: early childhood asthma and parents’ experiences of the diagnostic process
7个月前
已完结
[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China]
7个月前
已完结
Efficacy and safety of telitacicept in patients with lupus nephritis: a single-center, real-world retrospective study
10个月前
已完结
Telitacicept: First Approval
10个月前
已完结
Recommendations for the diagnosis and management of lupus nephritis in China
10个月前
已完结
没有进行任何应助
感谢
13小时前
内容错误
7个月前
帮大忙了
10个月前
速度真快
10个月前
速度真快
10个月前
速度真快
10个月前
点赞
10个月前
感谢
10个月前
帮大忙了
10个月前
感谢
10个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论